No large human randomized controlled trial exists for either compound in any musculoskeletal use
Despite the fact that we do not like to get stuck with needles, just from routine vaccinations and blood tests you can expect to be stuck at least 165 times over your lifetime
To reach a mutual benefit of our customers, suppliers, the society and ourselves for CAS 88-04-0, CAS 657-27-2, CAS 69-72-7
Although preclinical research indicates a favorable safety profile for BPC-157, even at high doses, the lack of comprehensive clinical data necessitates caution in research applications involving this peptide
Risks include injection site reactions, rare allergic responses, and hypokalaemia during treatment of severe anaemia
These hypotheses will need to be explored in a randomized study